Abstract:Objective To investigate the clinical value of contrast-enhanced ultrasound (CEUS) in differential diagnosis of benign and malignant peripheral lung tumor lesions. Methods According to the result of enhanced CT scans, 45 patients with peripheral lung tumor and pleural adhesion of the lungs were collected. Conventional ultrasound scanning, CEUS and pathological biopsy were used. Pathological biopsy results were gold standard to evaluate the clinical value of CEUS in the differential diagnosis of benign and malignant peripheral lung tumors. Results The enhancement time of the benign masses [(8.48 ± 1.45) s] was significantly shorter than that of the malignant tumors [(10.89 ± 2.70) s, P < 0.05]. The clearance time of the malignant tumors [(100.63 ± 13.63) s] was significantly shorter than that of benign masses [(137.57 ± 12.61) s, P < 0.05]. The diagnostic accuracy of enhanced CT and CEUS was 73.3% and 77.8% respectively; when used in combination, the diagnostic accuracy was 93.3% in differential diagnosis of benign and malignant peripheral lung tumor lesions. The diagnostic accuracy rate of CT combined with CEUS was obviously higher than that of CT or CEUS alone (P < 0.05). When pathological biopsy was taken as the gold standard, the diagnostic sensitivity of enhanced CT combined with CEUS was 95% and the specificity was 92%, Kappa test indicated an excellent consistency. Conclusions CEUS is important in the clinical differential diagnosis of benign and malignant lung tumors. CEUS combined with enhanced CT scan can improve the diagnostic accuracy.